Cindy Geyer

Cindy Geyer is a contributor to the field of lifestyle medicine. Her published research in the American Journal of Lifestyle Medicine examines the relationships between weight, chronic pain, and mood, integrative approaches to sleep, and the role of psychosocial support in breast cancer treatment. She also discusses the impact of inflammation, insulin resistance, and metabolic dysfunction on cardiovascular disease.

9 claims checked on air: 1 contradicted 8 supported

What they said on air - contradicted

0:10:12contradictedhighIt's Not Cholesterol. Inflammation Is What's Actually Causin

Small HDL particles are less capable of clearing LDL particles and facilitating reverse cholesterol transport than larger HDL particles.

"The same is true for HDL. We've historically thought of HDL as being the good, healthy cholesterol, but size matters there, too. Small HDL doesn't seem to be as able to cart out the bad LDL and get rid of it." (said at 0:10:12)

The speaker states the relationship between HDL particle size and cholesterol removal backwards. In reverse cholesterol transport, small, dense HDL particles (such as discoidal HDL and pre-beta HDL) are the primary and most potent mediators of cellular cholesterol efflux via the ABCA1 (ATP-binding cassette transporter A1) pathway. Experimental and clinical studies consistently demonstrate that cholesterol efflux capacity increases as HDL particle size decreases, with small HDL particles displaying 3- to 5-fold greater efflux capacity than larger HDL subfractions.

Fact-checked episodes

Publications